Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 728 of 1,261
  1. US 9163068

    Influenza virus recombinant proteins

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  2. US 9163022

    Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

    VTV THERAPEUTICS LLC · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  3. US 9162980

    Anti-depression compounds

    The Board of Regents of the University of Texas System · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  4. US 9161990

    Hydrochloride salts of a glycopeptide-cephalosporin antbiotic compond

    THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  5. US 9161969

    Protection against influenza infection by granulocyte-macrophage colony stimulating factor

    The Board of Regents of the University of Texas System · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  6. US 9161935

    Use of laquinimod for treating Crohn's disease patients who failed first-line anti-TNF therapy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  7. US 9161735

    Systems, compositions, and methods for local imaging and treatment of pain

    The Regents of the University of California · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  8. US 9163258

    Method for the treatment of obesity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  9. US 9162989

    2,4-Pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  10. US 9162968

    Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis

    Northwestern University · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  11. US 9161948

    Peptide oligonucleotide conjugates

    Sarepta Therapeutics, Inc. · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  12. US 9163271

    Methods and compositions for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs

    The Regents of the University of California · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  13. US 9163245

    Compositions for linking zinc finger modules

    Sangamo Biosciences, Inc. · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  14. US 9163235

    Inhibitors of the miR-15 family of micro-RNAs

    MIRAGEN THERAPEUTICS, INC. · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  15. US 9163085

    Anti-OX40 antibodies and methods of treating cancer

    The Board of Regents of the University of Texas System · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  16. US 9163215

    Generation of lineage-restricted progenitor cells from differentiated cells

    The Regents of the University of California · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  17. US 9163244

    Suppressors of CpG oligonucleotides and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  18. US 9163236

    Pharmaceutical composition comprising NANOG SHRNA, and method of using NANOG SHRNA to treat cancer

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  19. US 9163248

    Targeting pseudotyped retroviral vectors

    The Regents of the University of California · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  20. US 9163042

    Prodrugs of pyridone amides useful as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  21. US 9162982

    4-[2-(2-fluorophenoxy methyl)phenyl]piperidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  22. US 9161984

    Formulations and methods of use for alpha connexin C-terminal (ACT) peptides

    FIRSTSTRING RESEARCH, INC. · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  23. US 9161936

    Laquinimod for treatment of GABA mediated disorders

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted
  24. US 9161995

    Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (CFTR) gene

    Sangamo Biosciences, Inc. · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.